Results 131 to 140 of about 736 (146)
Abstract Ciprofol is a propofol analogue with improved pharmacokinetic properties. A multi‐centre, non‐inferiority trial was conducted to compare the deep sedation properties of ciprofol and propofol with a non‐inferiority margin of 8% in patients undergoing gastroscopy and colonoscopy.
Ya-Ping Wang +2 more
exaly +2 more sources
Ciprofol, a novel γ-aminobutyric acid receptor agonist, outperforms propofol with minimal cardiovascular effects, higher potency, reduced injection pain, and a broader safety margin.
Jia-Ning Hu +5 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Effect of Different Doses of Ciprofol in Patients with Painless Gastrointestinal Endoscopy
Drug Design, Development and Therapy, 2023Xue-Ke Du
exaly
Ciprofol: A Novel Medication from Development towards Clinical Use
Translational Perioperative and Pain Medicine, 2021exaly
The efficacy and safety of remimazolam besylate, ciprofol, and propofol during hysteroscopy
Frontiers in PharmacologyHaiyan Lan, Qiaomin Xu
exaly

